Journal article
Growth Hormone Therapy in Heart Failure: Where Are We Now?
Abstract
Despite improvement in survival with angiotensin-converting enzyme inhibitors and beta blockers, clinical events for patients with heart failure remain elevated. New therapies for heart failure are needed to improve functional capacity, quality of life, and prognosis. Growth hormone exerts direct and indirect effects on cardiac structure and function. Experimental models of heart failure and small studies have demonstrated significant …
Authors
Demers C; McKelvie RS
Journal
Congestive Heart Failure, Vol. 9, No. 2, pp. 84–90
Publisher
Wiley
Publication Date
March 2003
DOI
10.1111/j.1527-5299.2003.00283.x
ISSN
1527-5299